Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples